Troriluzole (BHV-4157) in Adult Participants With Obsessive Compulsive Disorder

PHASE2/PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

426

Participants

Timeline

Start Date

December 19, 2017

Primary Completion Date

June 2, 2020

Study Completion Date

March 31, 2026

Conditions
Obsessive-Compulsive Disorder
Interventions
DRUG

Troriluzole

Troriluzole, 140 mg capsules once daily (QD) orally for the first 4 weeks and 200 mg (140 mg+ 60 mg capsules QD) for an additional 8 weeks

DRUG

Placebo

Matching capsule once daily (QD)

Trial Locations (57)

10032

New York State Psychiatric Institute, New York

10312

Richmond Behavioral Associates, Staten Island

11021

Bio Behavioral Institute, Great Neck

11229

Integrative Clinical Trials LLC, Brooklyn

14618

Finger Lakes Clinical Research, Rochester

19063

Suburban Research Associates, Media

19104

University of Pennsylvania, Philadelphia

21208

Pharmasite Research, Inc., Pikesville

22903

Psychiatric Alliance of the Blue Ridge, Inc., Charlottesville

28211

New Hope Clinical Research, Charlotte

30030

iResearch Atlanta, LLC, Decatur

31405

iResearch Savannah, Savannah

32256

Clinical Neuroscience Solutions, Inc, Jacksonville

32606

University of Florida Department of Psychiatry, Gainesville

32763

Medical Research Group of Central Florida, Orange City

32801

Clinical Neuroscience Solutions, Inc, Orlando

33016

Galiz Research, Hialeah

33162

Harmony Clinical Research, North Miami Beach

33912

Gulfcoast Clinical Research Center, Fort Myers

34741

SIH Research, Inc, Kissimmee

38119

Clinical Neuroscience Solutions, Inc., Memphis

39232

Precise Research Centers, Flowood

45242

New Horizons Clinical Research, Cincinnati

45417

Midwest Clinical Research Center, Dayton

48105

Michigan Clinical Research PC, Ann Arbor

60563

AMR-Baber Research, Inc, Naperville

60634

Chicago Research Center, Chicago

60637

University of Chicago Department of Psychiatry & Behavioral Neuroscience, Chicago

66208

Phoenix Medical Research, Inc., Prairie Village

67207

Heartland Research Associates, LLC, Wichita

72211

Preferred Research Partners, Inc., Little Rock

75115

InSite Clinical Research, DeSoto

75231

FutureSearch Trials of Dallas, LP, Dallas

77030

Baylor College of Medicine, Houston

80209

Mountain View Clinical Research, Inc., Denver

85226

Metropolitan Neuro Behavioral Institute, Chandler

90024

CalNeuro Research Group, Los Angeles

91786

Pacific Clinical Research Medical Group, Upland

91945

Synergy Research San Diego, Lemon Grove

92037

University of California San Diego, La Jolla

92078

Artemis Institute for Clinical Research, San Marcos

92103

Artemis Institute for Clinical Research, San Diego

92270

Desert Valley Research, Rancho Mirage

92845

Collaborative Neuroscience Network, LLC, Garden Grove

92868

NRC Research Institute, Orange

94607

Pacific Research Partners, LLC, Oakland

97210

Summit Research Network (Oregon) Inc., Portland

98007

Northwest Clinical Research Center, Bellevue

94305-5717

Stanford University, Department of Psychiatry and Behavioral Sciences, Stanford

06106

Institute of Living / Hartford Hospital, Hartford

06519

Yale University, New Haven

06360

Comprehensive Psychiatric Care, Norwich

02478

McLean Hospital, Belmont

02114

Massachusetts General Hospital, Boston

02131

Boston Clinical Trials, Boston

03801

ActivMed Practices and Research, Inc., Portsmouth

08028

Center for Emotional Fitness, Cherry Hill

Sponsors
All Listed Sponsors
lead

Biohaven Pharmaceuticals, Inc.

INDUSTRY